Why Cann Pharmaceutical Australia and better™?
Our unique and proprietary growing technologies, varietal strains and nutrient regiments provide the platform to produce highly advanced MGC medicine. With the extensive experience gained over years of growing in California and Israel, Cann Israel (better™) has developed advanced and proven growing systems and plant genetics (strains) to produce high quality medicine.
better™ strives to provide healing for patients, while also promoting ecological sustainability.
Cann Pharmaceutical Australia is leveraging the benefits of better™’s deep and extensive background in treating thousands of patients in Israel to bring this knowledge, as well as breadth of MGC products to Australians in a prime partnership between Australia and Israel.
In addition, Cann Pharmaceutical Australia is incorporating these MGC products in key research and clinical trials in Australia to expand the medical research knowledge base and look to provide MGC treatments to bring relief to patients with medical conditions not materially assisted by current treatments.
Cann Pharmaceutical Australia is investing significantly in Australia and has applied for a cultivation license, which will assist in generating jobs and revenues at State Government level.
The Chairman of Cann Pharmaceutical Ltd in Israel is Mr Dani Naveh, former Minister of Health in Israel.
The medical cannabis sector should combine two scientific disciplines with different technologies:
- Agro-botanic and
Combining the two is complex, challenging and requires continuously investing in research & development of new advanced technologies, positioning Cann Pharmaceutical at the forefront of the industry.
Our Medical Grade Cannabis is a standardized and stable natural medicine using our unique growing technologies that combine conventional and next generation agronomic and botanic technologies across various agricultural industries.
This guarantees that each product contains a consistent level of active pharmaceutical compounds (THC and CBD among other cannabinoids) free from any contaminants.
The Cann Pharmaceutical Australia leadership team that includes Managing Director Andrew McCrea also consists of highly experienced and qualified legal, medical and seasoned business executives with deep and diversified entrepreneurial and management experience.
The operational team draws upon the technical prowess and a dedication to assist those less fortunate with the exceptional quality and range of our products, developed through years of experience in Israel and California.
Medical Advisory Board
The company’s board of advisors includes world renowned medical experts with extensive medical knowledge and proven business experience in the medical cannabis industry, representing a vast variety of modalities – doctors, scientists and academics.